NIH-funded research Sbir 2 grant

A safe, fast, and lower-cost way to remove large uterus tissue during minimally invasive hysterectomy

Official title: A Safe, Fast, and Cost-Effective System for Tissue Removal in Laparoscopic Hysterectomy and Other Minimally Invasive Surgery

Funded at Claria Medical, INC. · NIH-11416770 · Data updated 2026-11-12

A new device called the Claria System aims to remove large uteruses quickly and safely during minimally invasive hysterectomy and other surgeries, while reducing costs.

More Hysterectomy research and trials

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionClaria Medical, INC.
NIH-funded
Lab location1 site (Mountain View, UNITED STATES)
Project startSeptember 1, 2022
Project endAugust 31, 2027
Funding year2026
Award (this year)$107,203
NIH project number5R44HD105575-04
Project IDNIH-11416770 on NIH RePORTER

Who could benefit from this research

Could help

People undergoing hysterectomy or similar procedures who currently face higher risk from uncontained tissue removal and are candidates for minimally invasive surgery.

Less likely to help

Patients planned for open surgery or those not undergoing tissue morcellation could have limited benefit.

What this research studies

This project focuses on a device-based solution to improve tissue removal during minimally invasive gynecologic and related surgeries. It aims to contain tissue and cancer cells during morcellation to lower the risk of spreading hidden cancers. The team at Claria Medical is testing a system designed to be faster and more affordable than traditional methods, potentially shortening hospital stays. If successful, it could make minimally invasive options safer for patients with fibroids and other uterine conditions.

Why it matters

Potential benefit: If the system works as hoped, patients could have safer, quicker, and less expensive minimally invasive surgeries with lower risk of spreading hidden cancer.

How similar studies have gone: Previous approaches were slower and less reliable at containing tissue, so this represents a novel improvement with early evidence suggesting potential benefits.

Where this research is happening

  • Claria Medical, INC.
    Mountain View, United States
    Active

Researchers

  • Principal investigator: Francis, Daniel — Claria Medical, INC.
  • Study coordinator: Francis, Daniel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.